CLINICAL ROLE -
Clinical Outcomes of Oral Anticancer Regimens in NSCLC Patients Managed in an Integrated Health-System Specialty Pharmacy Program
Pharmacist interactions provide significant benefits for patients with non-small cell lung cancer treated with oral oncolytics.
Read More